Guest guest Posted February 7, 2011 Report Share Posted February 7, 2011 Source: Ophthalmologe | Posted 1 week ago Acute loss of vision during therapy of chronic hepatitis C; Salgado JP, Khoramnia R, Maier MM, Lohmann CP, Winkler von Mohrenfels C; Der Ophthalmologe (Jan 2011) A patient undergoing combined therapy of chronic hepatitis C with pegylated interferon-á-2a (PEG-IFN-á-2a) and ribavirin suddenly developed severe loss of visual acuity. A central vein occlusion with macular edema was found and intravitreal injections of bevacizumab were initiated. Retinal occlusion is a known complication of therapy with pegylated interferon-á-2a and ribavirin. An interdisciplinary assessment of patients treated for a chronic hepatitis C as well as an early anti-VEGF administration can be helpful in the therapy of this complication of chronic hepatitis C. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.